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The macrocyclic antiviral drug xylyl-bicyclam blocks entry of HIV
into cells by targeting the CXCR4 coreceptor, a seven-helix trans-
membrane G-protein-coupled receptor. Its affinity for CXCR4 is
enhanced by binding to Cu2, Ni2, or Zn2. Metallocyclams have
a rich configurational chemistry and proteins may bind selectively
to specific metallocyclam configurations. Our studies of lysozyme
reveal structural details of protein–metallocyclam interactions that
are important for receptor recognition. Solution NMR studies show
that Cu-cyclam interacts with specific tryptophan residues of ly-
sozyme (Trp-62, Trp-63, and Trp-123). Two major binding sites for
both Cu-cyclam and Cu2-xylyl-bicyclam were detected by x-ray
crystallography. In the first site, Cu2 in one cyclam ring of
Cu2-xylyl-bicyclam adopts a trans configuration and is coordinated
to a carboxylate oxygen of Asp-101, whereas for Cu-cyclam two
ring NH groups form H bonds to the carboxylate oxygens of
Asp-101, stabilizing an unusual cis (folded) cyclam configuration.
For both complexes in this site, a cyclam ring is sandwiched
between the indole side chains of two tryptophan residues (Trp-62
and Trp-63). In the second site, a trans cyclam ring is stacked on
Trp-123 and H bonded to the backbone carbonyl of Gly-117. We
show that there is a pocket in a model of the human CXCR4
coreceptor in which trans and cis configurations of metallobicyclam
can bind by direct metal coordination to carboxylate side chains,
cyclam-NHcarboxylate H bonding, together with hydrophobic
interactions with tryptophan residues. These studies provide a
structural basis for the design of macrocycles that bind stereospe-
cifically to G-coupled and other protein receptors.
zinc  copper  x-ray crystallography  NMR  CXCR4 coreceptor
Cyclam (1,4,8,11-tetraazacyclotetradecane; Fig. 1) derivativesblock entry of HIV into cells by binding specifically to the
CXCR4 coreceptor (1), a G-protein-coupled, seven-helix trans-
membrane protein. An example is xylyl-bicyclam (AMD3100),
which has two cyclam rings connected by a p-phenylenebis(meth-
ylene) linker (Fig. 1) and is a highly potent anti-HIV drug (2, 3).
AMD3100 has recently been on clinical trial for the treatment of
AIDS. Additional medical interest in cyclams arises from their
ability to mobilize stem cells and to carry diagnostic and
therapeutic radionucleotides (4), and from their potential use in
transplant, inflammation, and cancer therapy (5). Metal ions
such as Zn2 and Cu2 bind to cyclam strongly (log K values15
and 27, respectively (6)) and relatively rapidly (7), and it seems
likely that metal complexation by xylyl-bicyclam is involved in
the mechanism of action of the drug in vivo. For metal-bicyclam
complexes, there is a close correlation (8) between antiviral
activity and binding to the coreceptor CXCR4 as monitored by
inhibition of 12G5mAb binding and the intracellular Ca2 signal
induced by SDF-1 chemokine, the order of decreasing activity
being Zn2  Ni2  Cu2  Co3  Pd2. The affinity of
AMD3100 for the CXCR4 receptor is enhanced by factors of 7,
36, and 50 by incorporation of Cu2, Zn2, or Ni2, respectively,
into the cyclam rings (9), and a similar metal-induced enhance-
ment in CXCR4 affinity is observed for cyclam itself, although
the affinity for the receptor is much less. Aspartate carboxylate
groups of CXCR4 (especially Asp-171 and Asp 262) have been
implicated in the bicyclam binding site (9, 10), and models of
CXCR4 containing (carboxylate)OHN(cyclam) H bonding
and carboxylate(O)-metal(cyclam) coordination have been built
(9–11).
Metal cyclam complexes have a potentially rich configura-
tional chemistry (4, 12). Each of the coordinated N atoms is
chiral. The metal ion can commonly be 4-, 5-, or 6-coordinate,
and symmetrical trans configurations can fold to give cis struc-
tures, as illustrated for trans-V in Fig. 1. In view of the targeting
of anti-HIV cyclam derivatives to CXCR4, it is important to
understand the nature of the interactions that determine their
binding sites on proteins and in particular whether proteins can
recognize different configurations of metal cyclams selectively.
However, there appear to be no reported structures of protein
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Fig. 1. Structures of the major configurations of a metal cyclam and of
xylyl-bicyclam (the hydrochloride salt is the drug AMD3100).
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adducts of metal cyclams. In particular, we have suggested (11)
that carboxylate groups in a protein positioned above the faces
of a metallocyclam might stabilize the unusual cis-V configura-
tion. To explore the structures of protein–cyclam adducts, we
have studied the binding of metal–cyclam and metal–bicyclam
complexes to lysozyme, chosen as a model protein because it is
readily crystallized (e.g., ref. 13) and the active site contains
carboxylates from Glu-35 and Asp-52 in close proximity. These
amino acid side chains are known to bind to metal ions such as
Gd3 (14). Our data provide structural insight into specific polar
and nonpolar interactions involved in the recognition of metal-
locyclams by proteins, features that can be found in a binding
pocket for anti-HIV metallocyclams on the human CXCR4
coreceptor.
Experimental Section
Materials. Hen egg white lysozyme (HEWL) and cyclam were
purchased from Sigma. Xylyl-bicyclam and Zn2(xylyl-bicyclam)-
(ClO4)2 were prepared as previously described (11). (15N)Cy-
clam was synthesized by using the route shown in Scheme 1 with
(15N)phthalimide (98 atom % 15N) and (15N)glycine (99 atom %
15N), both from Aldrich, as sources of 15N, and the Zn complex
was prepared and characterized as described in ref. 15.
[Cu(cyclam)(H2O)2](OAc)2 (1). Cyclam (400.7 mg, 2 mmol) was dis-
solved in methanol (50 ml), and Cu(OAc)2 (363.5 mg, 2 mmol)
was added. The reaction mixture was heated to reflux, stirred for
2 h, and then filtered to give a clear, purple solution. The solvent
was removed in vacuo, and the purple solid was recrystallized by
slow diffusion of methanol into ether to give purple needle
crystals of 12MeOH (mz  322.2 [CuC12N4H27O2], 262.0
[CuC10N4H23]). Samples of this complex used in NMR studies
did not contain MeOH, which is readily lost on drying the
complex.
[Cu2(xylyl-bicyclam)(OAc)4] (2). Xylyl-bicyclam (50.2 mg, 0.1 mmol)
was dissolved in methanol (5 ml) and Cu(OAc)2 (36.9 mg, 0.2
mmol) was added. The dark blue solution was heated under
reflux for 2 h, filtered, and concentrated on a rotary evaporator
to give a dark blue crystalline material, which was recrystallized
from methanol to give dark blue crystals (mz  805.1,
[Cu2C34N8O6H63]).
Lysozyme Crystallization.The hanging-drop method was used. The
reservoir solution contained 100 l of 50 mM acetate buffer, pH
4.5, 200 l of saturated NaCl solution, and 700 l of distilled
water, and the hanging drop contained 2.5 l of HEWL (50
mgml1 in acetate buffer) and 2.5 l of the reservoir solution.
Crystals suitable for x-ray diffraction grew at 277 K within a
week. Attempts to cocrystallize adducts of HEWL with complex
2 or with the Zn analogue were unsuccessful.
Crystal Soaking. Soaking was carried out for 5 days at 288 K with
HEWL crystals in drops to which either solid 1 had been added
(to saturation) or 2 had been added as a saturated solution in the
well solution. Soaked crystals became purple, and they were
removed in a cryoloop and frozen in liquid nitrogen by using type
B immersion oil as a cryoprotectant.
X-Ray Crystallography. Diffraction data for complex 1 were col-
lected with Mo-K radiation at 150 K on a Bruker SMART
APEX charge-coupled device diffractometer equipped with an
Oxford Cryosystems low-temperature device. Systematic errors
were treated with SADABS (16). The structure was solved by
Patterson methods (DIRDIF (17)) and refined by least squares
against F2 (CRYSTALS (18)). H atoms were placed on C in
calculated positions, but those attached to N and O were located
in difference maps and refined. Crystal data: Orthorhombic,
space group Pbca, a  15.9421(7) Å, b  7.0819(3) Å, and c 
20.9833(10) Å. The final conventional R factor was 0.0341; other
data have been deposited in the Cambridge Structural Database.
Diffraction data for HEWL complexes were collected at
Station 14.2 at the Daresbury Synchrotron Radiation Source and
processed by using the programs MOSFLM and SCALA (19). The
initial structure was solved by using a reported lysozyme struc-
ture (ref. 13, PDB code 193L). Refinement was performed by
using the program REFMAC (20) with waters being added by
ARP/WARP, and manual checking and correction were performed
with the program O (21). Data collection and refinement are
summarized in Table 1. The positions of the metal ions in the
structures of the adducts were confirmed in anomalous differ-
ence maps produced from data on HEWL crystals soaked with
Ni-cyclam at a wavelength of 1.488 Å (Daresbury Synchrotron
Radiation Source Station 14.1; data not shown).
NMR Spectroscopy. 1H NMR data were acquired over a range of
15 ppm at 298 K on a Bruker Avance 600 (1H  599.92 MHz)
NMR spectrometer using a TXI [1H, 13C, 15N] cryoprobe,
equipped with z-field gradients. 1H chemical shifts were refer-
enced internally to dioxane (3.75 ppm). All NMR experiments
were performed in 90% H2O10% D2O. The water resonance
was suppressed by presaturation. Standard pulse sequences were
used for 2D total correlation spectroscopy (TOCSY) and cor-
relation spectroscopy (COSY) (mixing times of 60 and 80 ms,
respectively).
The pH of 5 mM solutions of HEWL in 90% H2O10% D2O
used for NMR titrations was adjusted to 4.6 with 0.1 M HCl.
Titrations were carried out by adding microliter aliquots of
aqueous Cu-cyclam (125 mM, pH 4.6). The assignments for 1H
NMR resonances of HEWL are based on those given by Noda
et al. (22).
Mass Spectrometry. Positive-ion electrospray ionization mass
spectra were acquired on a Micromass Platform II mass spec-
trometer, collision energy 4 eV, source temperature 353 K,
capillary voltage 1.5 kV, cone voltage 25 V (Cu complexes 1 and
2) or 90 V (protein). Aqueous solutions were diluted 1:1 with
acetonitrile before injection.




Space group P43212 P43212
Unit cell
a, Å 77.9064 78.258
b, Å 77.9064 78.258
c, Å 37.7624 37.900
, , , ° 90, 90, 90 90, 90, 90




Observed reflections 81,871 111,324
Unique reflections 12,234 16,097
I* 6.1 (2.0) 8.5 (2.0)
Completeness,* % 99.9 (99.9) 100 (100)
Multiplicity* 6.7 (6.8) 6.9 (6.9)
Rsym,* % 8.1 (34) 6.1 (36.2)
Refinement
RRfree, % 17.623.3 17.722.3
rms bonds, Å 0.015 0.014
rms angles, ° 1.577 1.55
Average isotropic B, Å2 19.55 17.63
*Numbers in parentheses refer to high shell.






Supporting Information. Scheme 1 showing the synthetic route to
(15N)cyclam and Figs. 4–10 showing 1D and 2D NMR spectra,
x-ray crystal structure of complex 12MeOH, lysozyme crystals,
crystal packing, contact distances, and comparison of trypto-
phan sandwiches are published as supporting information on the
PNAS web site. Crystallographic data have also been deposited
as follows: complex 1 in the Cambridge Crystallographic Data
Centre CCDC 260045, Cu-cyclam-HEWL in the Protein Data
Bank 1YIK, and Cu2-bicyclam-HEWL in the Protein Data Bank
1YIL.
Results and Discussion
Interaction of Zn-Cyclams with Lysozyme. First we sought to dem-
onstrate that Zn2-bicyclam binds to lysozyme. Electrospray
ionization mass spectrometry of an aqueous solution containing
lysozyme and Zn2(bicyclam)(ClO4)2 in a 1:1 molar ratio gave two
well resolved series of charged states with masses in the trans-
formed spectrum of 14,308 1 and 14,943 9Da corresponding
to lysozyme and an adduct with [Zn2(bicyclam)]4, respectively.
An interaction of Zn-cyclam with HEWL was detected by using
Zn{(15N)cyclam}Cl2 and 2D [1H, 15N] NMR spectroscopy (Fig.
4). Of the three cross-peaks for the trans-I, trans-III, and cis-V
configurations of Zn-cyclam, those for trans-I and cis-V shifted
by 0.04 and 0.13 ppm, respectively, in the presence of HEWL
{calculated from [(HN)2 (N 0.17)2]1/2 (23)}, whereas that
for trans-III was unaffected. These experiments show that both
zinc cyclam and zinc bicyclam bind to HEWL, and thus suggest
that HEWL is a useful model for identification of specific
interactions relevant to the binding of metallocyclams to the
CXCR4 coreceptor.
Cu2-xylyl-bicyclam also exhibits anti-HIV activity, although it
is less active than Zn2-xylyl-bicyclam (8). We used Cu2-cyclam
as a paramagnetic probe to investigate interactions of metal-
locyclams with the model target protein HEWL in solution. The
structures of Cu-cyclam (12MeOH, Fig. 5) and Zn-cyclam
{[Zn(cyclam)(H2O)2](OAc)2 (15)} are similar.
Cu-Cyclam–HEWL Interactions in Solution.Resonances from protons
in the protein that are within a few ångstroms of Cu2 in a bound
Cu-cyclam would be expected to broaden significantly on ac-
count of the paramagnetism of Cu2 [3d9; dipolar broadening 	
r6 (24), where r Cu–H distance]. The main features of the 1D
1H NMR spectrum of HEWL were unchanged after addition of
up to 10 mol equiv of the paramagnetic complex 1 (Fig. 6), which
indicated that the interaction had little effect on the overall
protein fold. However, specific Trp resonances broadened, as
seen in 1D (Fig. 2) and 2D (Fig. 6) spectra. Line-broadening of
tryptophan indole NH resonances decreased in the order (Fig.
2): Trp-62, Trp-63 Trp-123 Trp-108, Trp-111, with Trp-108
and Trp-111 being little affected by Cu-cyclam. Cu-cyclam also
had little effect on the H and H resonances of the only His
residue in lysozyme, His-15. Next we used x-ray diffraction to
study the binding of Cu-cyclam and Cu2-bicyclam to crystals of
HEWL.
Cu-(Bi)Cyclam Binding Sites in Crystalline HEWL. Colorless HEWL
crystals turned purple on soaking in solutions containing either
Cu-cyclam 1 or Cu2-bicyclam 2 (Fig. 7). The x-ray structures of
the adducts were solved to a resolution of 1.75 and 1.6 Å,
respectively. The overall structure of lysozyme is not changed by
formation of adducts with either complex 1 or complex 2. The
positions of the copper atoms in both the monocyclam and
bicyclam structures were unequivocally detected as strong peaks
in an Fo Fcmap. In each case, this revealed two binding sites
per asymmetric unit.
The metal binding positions are similar in the monocyclam
and the bicyclam structures. Site 1 is close to the side chain of
Asp-101, whereas site 2 is closest to the side chain of Trp-123 and
the backbone carbonyl of Gly-117. These residues are on differ-
ent regions on the protein surface. The packing of the protein
molecules in the crystal brings the binding sites close to each
other (Fig. 8). The crystal packing and the interaction between
the cyclam rings therefore appear to play a crucial role in the
formation of the binding site in the crystal.
In the structure of Cu2-bicyclam-HEWL, two cyclam rings
were readily identified. Both adopt trans configurations (Fig.
3A). No electron density was present for the p-phenylenebis-
(methylene) group that links the two cyclam rings. Although the
rings in the two sites are close (Cu–Cu distance 8.45 Å), it was
not possible to model the two cyclam rings as part of a single
bicyclam unit (therefore only monocyclam rings were built and
refined). The next closest cyclam ring in the crystal is too distant
(Cu–Cu distance 14.87 Å) to be modeled as part of a single
bicyclam. Hence it appears that the cyclam rings in sites 1 and
2 belong to two different Cu2-bicyclam molecules.
In Cu-cyclam-HEWL, the Cu in site 1 is in a slightly different
position from that in the bicyclam structure, and the cyclam ring
in this structure has strong density consistent with a cis config-
uration. Copper in site 2 is in a position similar to that found in
the bicyclam structure, and the planarity of the cyclam ring is
indicative of the presence of a trans configuration (Fig. 3B).
Cu-cyclam itself in 12MeOH adopts the trans-III configuration
even though carboxylate groups are present from acetate, the
counter anion (Fig. 5). It is evident, therefore, that the protein
plays an important role in stabilizing the bound cis configuration
in site 1.
Metal Coordination, H Bonding, and Hydrophobic Interactions. In site
2, the cyclams in both the monocyclam and bicyclam structures
adopt trans configurations. The trans-III configuration is com-
mon for octahedral metal cyclam complexes, and trans-I is
Fig. 2. Effect of Cu-cyclam on tryptophan indole NH resonances of lysozyme.
(Lower) The low-field region of the 1H NMR spectrum of HEWL in 90%
H2O10% D2O before and after addition of 10 mol equiv of the Cu-cyclam
complex 1. The pH of the solution (4.6) was chosen so as to be close to that
under which lysozyme readily crystallizes. As is evident from the plot of
linewidth versus Cu-cyclam concentration (Upper), there are specific para-
magnetic broadening effects on Trp-62, Trp-63, and Trp-123, implying that
these residues are close to the bound Cu2. The linewidth of the backbone NH
resonance of Cys-76 is also shown for comparison.
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common for square-planar metal cyclam complexes (4). The
cyclam ring stacks on Trp-123 and a (cyclam)CHOC(Gly-117)
hydrogen bond is formed (Fig. 3). Cu2 in the monocyclam
structure is also very weakly coordinated to a water molecule
(Cu–O 3.05 Å). Comparison of the positions of the cyclam in the
monocyclam and bicyclam structures reveals that although there
is very little movement in the Cu position (0.8 Å), there is a
distinct change in the orientation of the cyclam plane (Fig. 3C).
This change appears to be a consequence of the difference in
binding mode for the cyclam in site 1.
In site 1, the cyclam ring of Cu2-bicyclam has a trans config-
uration. The Cu2 in this cyclam coordinates directly to oxygen
O1 of the side chain of Asp-101 (Cu–O1 2.7 Å) and also very
weakly to a water molecule (Cu–O 3.07 Å) on the opposite side
of the ring (Fig. 9). In the monocyclam structure, the cyclam ring
adopts a cis configuration. The Cu in this ring does not coordi-
nate directly to Asp-101 and is in a significantly different position
from that found in the bicyclam structure (Cu movement 1.61 Å;
Fig. 3C). In this folded conformation, two NHO hydrogen
bonds are formed between the carboxylate oxygens of Asp-101
and two NH groups on one face of the cyclam ring (O2–N1 2.70
Å, O1–N10 2.93 Å, Fig. 9). The Cu in this ring coordinates weakly
to two water molecules (Cu–O 2.76, 2.88 Å). In both the
monocyclam and bicyclam structures, the cyclam in site 1 is
sandwiched between the indole rings of Trp-62 and Trp-63 and
stacks directly with Trp-62. This hydrophobic interaction with
tryptophan would therefore appear to be important for the
binding of these cyclams in both cis and trans configurations.
Girard et al. (25), in their search for heavy atom derivatives
useful in anomalous dispersion methods for solving protein
structures, have studied adducts of HEWL with Gd-HPDO3A,
the Gd3 complex of a derivative of the smaller [12]aneN4
macrocycle cyclen (1,4,7,10-tetraazacyclododecane). They were
unable to produce Gd-HPDO3A-HEWL by soaking, only by
cocrystallization. Intriguingly Gd-HPDO3A binds in the same
sites 1 and 2 as Cu-(bi)cyclam (Fig. 10C); the main protein
interaction is between Trp-62 and the cyclen macrocycle with no
direct metal coordination or involvement of H bonds with
Asp-101 (which is turned away from the site).
The difference in the orientation of the cyclam plane in site 2
of the monocyclam and bicyclam structures is likely to be a
consequence of the difference in conformation of the cyclam in
site 1. In both structures, the cyclams interact weakly with each
other (closest ring–ring distance 3.21 Å for bicyclam, 3.34 Å for
monocyclam, Figs. 9 and 10). The overlay of themonocyclam and
bicyclam structures (Fig. 3C) reveals that the different orienta-
tions of the plane conserve the tightness of the cyclam–cyclam
interaction (which would otherwise increase to 3.62 Å). It is
unclear why the cyclam in site 1 is in the trans configuration in
the bicyclam structure compared to the cis configuration for
monocyclam. The lack of difference between the protein struc-
tures does not provide any clues. It would therefore seem likely
that this difference is related to the presence of a linker between
the cyclam rings for bicyclam (although the linker is disordered).
What are the important factors in stabilization of the cis
cyclam configuration? In crystals of the zinc complex of the drug
xylyl-bicyclam, [Zn2(xylyl-bicyclam)(OAc2)2](OAc)22MeOH,
one acetate is bidentate and the other forms double H bonds to
the NH groups on the opposite face of the cyclam ring that
adopts the folded cis-V configuration (11). In the Cu-cyclam-
HEWL structure, there is no direct coordination of Cu2 to a
carboxylate, only NH hydrogen bonding, and the carboxylate
oxygen coordination sites appear to be occupied by weakly
bound water molecules. cis-Metallocyclams with two bound aqua
ligands are unusual, although Barefield et al. (26) prepared
cis-[Ni(cyclam)(H2O)2]Cl22H2O by displacement of a chelated
ethylenediamine by water under acidic conditions. In solution,
the interaction of carboxylate groups with Zn2 cyclams readily
leads to the formation of the folded cis-V configuration, equi-
libria being reached within 1 h at millimolar concentrations, at
298 K (11, 15).
CXCR4 Binding Sites. Previously (11) we built a model of the
human CXCR4 coreceptor based on the x-ray structure of
rhodopsin (27) and docked Zn2-bicyclam such that there is direct
coordination of Zn2 in one cyclam ring to the carboxylate of
Asp-171, and of Zn2 in the other to Asp-262. In the latter site,
Glu-288 on the opposite side of the ring can form double H
bonds to two ring NH groups, and the macrocycle folds into the
cis-V configuration. In the first site, a trans-I or trans-III con-
figuration is more likely for the cyclam ring. Inspection of the
same CXCR4 model now reveals that there are tryptophan
indole rings close to each of the docked cyclams (Fig. 3D).
Notable is the stacking of Trp-195 on the trans-cyclam ring that
contains Zn2 bound to Asp-171. These are all features seen in
the HEWL-(bi)cyclam structures. The hydrophobic interaction
of the N(CH2)2N and N(CH2)3N backbone of cyclam with
tryptophan indole rings has a parallel in the hydrophobic contact
of the N(CH2)3CH cyclic side-chain of proline with tryptophan
at some protein–protein interfaces, often as a Trp-Pro-Trp
Fig. 3. The two Cu-cyclam and Cu2-bicyclam binding sites in crystals of HEWL.
(A) Cu-bicyclam-HEWL. 2Fo Fc density is shown around the cyclams at 0.9.
No electron density is seen for the p-phenylenebis(methylene) linker. (B)
Cu-cyclam-HEWL. 2Fo  Fc density is shown around the cyclams at 0.9. (C)
Stereoview of an overlay of the cyclam positions in lysozyme. Color code:
orange, Cu2-bicyclam; green, Cu-cyclam. The sites are at the intersection of
three lysozyme molecules in the crystal (Fig. 8). Molecule 1 is green and
contains Asp-101, Trp-62, and Trp-63; molecule 2 is purple and contains
Trp-123; and molecule 3 is yellow and contains Gly-117. (D) A model showing
[Zn2(xylyl-bicyclam)]4 bound to the human coreceptor CXCR4 (11). One of
the cyclam rings in a trans configuration is stacked on Trp-195 and its Zn is
bound to Asp-171. The other cyclam ring has a folded configuration (cis) and
is close to Trp-283; its Zn is bound to Asp-262, and two ring NH groups are H
bonded to the oxygens of Glu-288.






sandwich, e.g., the IgE receptor (28) (Fig. 10D). Such hydro-
phobic interactions may therefore play a key role in the binding
of cyclam anti-HIV complexes to the CXCR4 coreceptor.
Conclusions
Cyclams, macrocyclic tetraamines, have a wide range of potential
uses in diagnosis and therapy (4). Antiviral bicyclams target the
membrane coreceptor protein CXCR4 (1), and coreceptor
binding is enhanced by the presence of Ni2, Cu2, or Zn2 in
the cyclam ring (9). Currently there are only structural models
of CXCR4–cyclam adducts (9–11). These models have empha-
sized the importance of aspartate carboxylate side chains of
CXCR4 in forming H bonds to cyclam NH groups and in
coordination to cyclam-bound metal ions. Cyclam rings in
metallocyclam complexes have configurational f lexibility and
in one model a folded cis configuration is stabilized by interac-
tions with carboxylate side chains (11). Although it would be
desirable to carry out structural studies directly on CXCR4, such
transmembrane proteins are very difficult to crystallize. To date,
the only member of this class of proteins for which the x-ray
crystal structure has been solved is bovine rhodopsin (27). We
found that anti-HIV metallocyclams bind to HEWL, which is
therefore a useful model for CXCR4.
The x-ray crystal structures of Cu-cyclam and Cu2-bicyclam
complexes of lysozyme establish that protein recognition can
involve a range of both polar and nonpolar interactions. These
include H bonding between the cyclam ring and protein carbox-
ylate groups, which, for the Cu-cyclam structure, anchors the
cyclam ring in the unusual folded cis configuration without direct
coordination of Cu2 to the protein. The presence of an addi-
tional cyclam ring, as in a bicyclam, can influence the configu-
ration adopted by the bound macrocycle. Intriguingly, hydro-
phobic interactions between the cyclam ring and the indole ring
of tryptophan, reminiscent of tryptophan-proline sandwiches
often found at protein–protein interfaces, occur not only in
crystals of HEWL but also in aqueous solution. Such tryptophan
stacking interactions are also possible in models of CXCR4
adducts of metallocyclams, which contain at the same time other
features important for metallocyclam docking, including metal
coordination to Asp-171 and Asp-262 (Fig. 3D). Tryptophan, an
amphipathic amino acid, is often located toward the surface
(interfacial regions) of membrane proteins (29), and may play a
crucial role in the recognition of antiviral metallocyclams and
other macrocycles by the protein coreceptor. Knowledge of these
diverse interactions will aid the design of new generations of
chemokine receptor antagonists.
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